ARF6 and intellectual disability, X-linked 1: Pharmacological inhibition of guanine nucleotide exchange on Arf6 using SencinH3 or NAV2729 has been used successfully to reduce levels of activated Arf6-GTP in cancer cells and could be a potential therapy for IQSEC2 disease [35].